Skip to content

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

Persimmon and Taylor Wimpey earnings to shed light on housebuilders

Taylor Wimpey and Persimmon earnings look to bring greater clarity on how the housebuilders are faring in the face of rising interest rates

Source: Bloomberg

Housebuilders in focus as investors await rate hike implications

The housing sector comes back in the spotlight this week, with earnings from Persimmon and Taylor Wimpey on Wednesday and Thursday respectively. Historically speaking, the housing sector has typically been protected during downturns, with governments aware of the negative economic implications if housing assets collapse in value. Unfortunately, the rampant inflation seen over the course of this crisis has left the Bank of England with little alternative than to ramp up rates in a bid to drive down CPI. This clearly poses a threat to the housing sector, with soaring mortgage rates dampening demand and lowering potential borrowing levels. Meanwhile, economic struggles will typically bring economic hardship, raising the likeliness of a house price collapse that in turn weakens demand and pricing power for housebuilders. Unfortunately, they are also squeezed from both sides, with the prospect of lower prices coming as rising costs dent margins. The chart below from the Rightmove HPI survey does highlight how interest rates have impacted the costs associated with home ownership.

Source: Rightmove

Data-wise, we have seen some jitters from the housing market, with the latest Rightmove fourth consecutive negative reading (-0.6%) bringing the most pessimistic view. Meanwhile, mortgage approvals have slumped to the lowest level since mid-2020, and housing completion data from the HMRC showed the lowest number since 2015. However, expectations of a wider collapse for the economy appears to be holding off for now, with some speculating that the widely anticipated recession may not occur at all. Nonetheless, with US inflation showing signs of stalling, there is a fear that central banks will find it difficult bringing CPI down towards target, dampening hopes of a swift pivot in monetary policy later in the year.

Persimmon

Persimmon report their full-year earnings on Wednesday 1 March, with traders keeping a close eye on the latest revenues, profits, and the outlook for the year ahead. We have already been provided a significant amount of data within the recent trading update, with sales and average prices both rising over the course of the year. However, forward sales are a clear concern, highlighting the likely focus the company’s outlook on Wednesday.

Source: Persimmon

The housebuilder is forecast to announce full-year revenues of £2.2 billion (+4.5%), thanks in no small part to an expected 25% jump in H2 revenues. Profits before tax are expected to rise from £966.8 million to £998.8 million (+3.3%). Finally, the earnings per share figure is predicted to come in at £2.43, compared with £2.47 for 2021. Looking at the analyst recommendations, it is clear that the concern around the sector brings plenty of uncertainty. A wide spread of views does centre around a majority of 10 analysts taking on a ‘hold’ view.

Source: Eikon

Persimmon shares have been heading lower over the course of this month, with price falling towards the £13.65 support level. A break below that level would bring about expectations of further downside, ending the recent recovery phase. However, it makes sense to be aware of a potential rebound from this recent descending channel, with a positive earnings report bringing the potential for a bullish breakout. A move through £14.77 would bring greater confidence of a bullish breakout and continuation of the bullish trend seen over the course of 2023 thus far.

Source: ProRealTime

Taylor Wimpey

Taylor Wimpey report on Thursday 2 March, coming off the back of a largely mixed trading statement released last month. Completions and the average sale price were lower than in 2021, while the order book value of £1.94 billion is also below the £2.55 billion seen in December 2021. Looking ahead to Thursday, markets are expecting to see full-year revenues of £4.44(+3.6%), with pre-tax profits of £886 million (+10%). Earnings per share are forecast to rise an impressive 7.7% to 19.39p. Analysts are relatively positive for the stock, with 12 of 19 providing some form of buy rating.

Source: Eikon

Looking at the chart, the company has been on a strong run of late, with price gaining 55% since the September low. That bullish trend relies on the continued trend of higher lows. As such, a bullish outlook holds unless price falls back below the £1.13 support level.

Source: ProRealTime

Act on share opportunities today

Go long or short on thousands of international stocks with spread bets and CFDs.

  • Get full exposure for a comparatively small deposit
  • Trade on spreads from just 0.1%
  • Get greater order book visibility with direct market access

See opportunity on a stock?

Try a risk-free trade in your demo account, and see whether you’re on to something.

  • Log in to your demo
  • Take your position
  • See whether your hunch pays off

See opportunity on a stock?

Don’t miss your chance – upgrade to a live account to take advantage.

  • Trade a huge range of popular stocks
  • Analyse and deal seamlessly on fast, intuitive charts
  • See and react to breaking news in-platform

See opportunity on a stock?

Don’t miss your chance. Log in to take advantage while conditions prevail.

Related articles

Live prices on most popular markets

  • Equities
  • Indices
  • Forex
  • Commodities


Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Monday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.


You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.


This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.